Endogena Therapeutics � EA-2351

Endogena Therapeutics, founded by Matthias Steger MD PhD, is a clinical-stage biotech company that discovers and develops first-in-class endogenous regenerative medicines to repair and regenerate tissues and organs that have deteriorated due to aging and genetic diseases. EA-2351 was discovered using artificial intelligence and is being developed to treat age-related macular degeneration.